Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21

被引:561
作者
Hatley, Mark E. [1 ,2 ]
Patrick, David M. [1 ]
Garcia, Matthew R. [2 ]
Richardson, James A. [1 ,3 ]
Bassel-Duby, Rhonda [1 ]
van Rooij, Eva [1 ]
Olson, Eric N. [1 ]
机构
[1] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA
[2] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA
[3] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
TUMOR-SUPPRESSOR GENE; BREAST-CANCER CELLS; TRANSFORMATION SUPPRESSOR; EXPRESSION SIGNATURE; PDCD4; EXPRESSION; AP-1; ACTIVITY; UP-REGULATION; MIR-21; APOPTOSIS; TARGETS;
D O I
10.1016/j.ccr.2010.08.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung cancer is the leading cause of cancer-related deaths in the world, and non-small-cell lung cancer (NSCLC) accounts for 80% of cases. MicroRNA-21 (miR-21) expression is increased and predicts poor survival in NSCLC. Although miR-21 function has been studied in vitro with cancer cell lines, the role of miR-21 in tumor development in vivo is unknown. We utilize transgenic mice with loss-of-function and gain-of-function miR-21 alleles combined with a model of NSCLC to determine the role of miR-21 in lung cancer. We show that overexpression of miR-21 enhances tumorigenesis and that genetic deletion of miR-21 partially protects against tumor formation. MiR-21 drives tumorigenesis through inhibition of negative regulators of the Ras/MEK/ERK pathway and inhibition of apoptosis.
引用
收藏
页码:282 / 293
页数:12
相关论文
共 69 条
[1]   Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis [J].
Afonja, O ;
Juste, D ;
Das, S ;
Matsuhashi, S ;
Samuels, HH .
ONCOGENE, 2004, 23 (49) :8135-8145
[2]   MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer [J].
Asangani, I. A. ;
Rasheed, S. A. K. ;
Nikolova, D. A. ;
Leupold, J. H. ;
Colburn, N. H. ;
Post, S. ;
Allgayer, H. .
ONCOGENE, 2008, 27 (15) :2128-2136
[3]   Defective expression of FasL and Bax in human lung cancer [J].
Badillo-Almaraz, I ;
Badillo-Salas, C ;
Villalobos, R ;
Avalos-Díaz, E ;
Herrera-Esparza, R .
CLINICAL AND EXPERIMENTAL MEDICINE, 2003, 3 (02) :106-112
[4]   The impact of microRNAs on protein output [J].
Baek, Daehyun ;
Villen, Judit ;
Shin, Chanseok ;
Camargo, Fernando D. ;
Gygi, Steven P. ;
Bartel, David P. .
NATURE, 2008, 455 (7209) :64-U38
[5]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[6]   siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression [J].
Bitomsky, N. ;
Wethkamp, N. ;
Marikkannu, R. ;
Klempnauer, K-H .
ONCOGENE, 2008, 27 (35) :4820-4829
[7]   MicroRNAs modulate the chemosensitivity of tumor cells [J].
Blower, Paul E. ;
Chung, Ji-Hyun ;
Verducci, Joseph S. ;
Lin, Shili ;
Park, Jong-Kook ;
Dai, Zunyan ;
Liu, Chang-Gong ;
Schmittgen, Thomas D. ;
Reinhold, William C. ;
Croce, Carlo M. ;
Weinstein, John N. ;
Sadee, Wolfgang .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (01) :1-9
[8]   p53 Regulates the Ras Circuit to Inhibit the Expression of a Cancer-Related Gene Signature by Various Molecular Pathways [J].
Buganim, Yosef ;
Solomon, Hilla ;
Rais, Yoach ;
Kistner, Daria ;
Nachmany, Ido ;
Brait, Mariana ;
Madar, Shalom ;
Goldstein, Ido ;
Kalo, Eyal ;
Adam, Nitzan ;
Gordin, Maya ;
Rivlin, Noa ;
Kogan, Ira ;
Brosh, Ran ;
Sefadia-Elad, Galit ;
Goldfinger, Naomi ;
Sidransky, David ;
Kloog, Yoel ;
Rotter, Varda .
CANCER RESEARCH, 2010, 70 (06) :2274-2284
[9]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[10]   Sprouty, an intracellular inhibitor of Ras signaling [J].
Casci, T ;
Vinós, J ;
Freeman, M .
CELL, 1999, 96 (05) :655-665